Skip to content

Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease

Samples Procurement for Patients With Colorectal Cancer, Gastric Cancer, and Non-malignant Disease Undergoing Surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03972956
Enrollment
1000
Registered
2019-06-04
Start date
2020-12-23
Completion date
2026-12-23
Last updated
2022-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Gastric Cancer, Gastric Ulcer, Hemorrhoids, Hernia, Inflammatory Bowel Diseases

Brief summary

The purposes of this study are to collect and store samples including blood, normal and tumor tissue from patients with colorectal cancer or gastric cancer, to collect and store samples including blood and/or normal gastrointestinal tissue (if available) from patients with non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD), gastric ulcer, hemorrhoids or hernia), and to create a database for the collected samples and allow access to relevant clinical information for current and future protocols.

Interventions

Samples are collected at the time of a scheduled surgery that is part of normal treatment. This study will not have any impact on the care or treatment the patient receives.

Sponsors

Renmin Hospital of Wuhan University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

* Any patient diagnosed with colorectal cancer, gastric cancer, non-malignant disease that requires undergoing surgery. * Must be willing and able to provide informed consent.

Exclusion criteria

* Subjects whose comorbidities would preclude diagnostic or therapeutic intervention.

Design outcomes

Primary

MeasureTime frameDescription
Confirmation of diagnosis by pathologistUp to 3 yearsOnce tissue is collected, those samples that have a confirmed diagnosis of disease by the pathologist will be used.

Countries

China

Contacts

Primary ContactTao Fu, MD
tfu001@whu.edu.cn+8613720120190

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026